Optimizing outcomes for patients with nonmetastatic pancreatic cancer

A multidisciplinary team from Mayo Clinic Comprehensive Cancer Center discuss the best options to optimize outcomes for patients with nonmetastatic pancreatic cancer. Experts include Mark J. Truty, M.D., M.S., surgical oncologist, Christopher L. Hallemeier, M.D., radiation oncologist, and Ajit H. Goenka, M.D., radiologist. The conversation was moderated by Tanios S. Bekaii-Saab, M.D., medical oncologist.

These pancreatic cancer experts discussed disease staging, measuring for optimal treatment response and the novel curative intent surgical options available for patients today.


February 6, 2023

Created by

Mayo Clinic

Related Presenters

Mark Truty, M.D., M.S.

Mark Truty, M.D., M.S.

Hepatobiliary and Pancreas Surgeon

Dr. Truty is a cancer surgeon with extensive training and experience in the management of Pancreatic, Liver, Biliary, Gastric, Small Bowel/Carcinoid, and Sarcoma Tumors.

View full profile